← Back to Search

Behavioral Intervention

Deep Brain Reorienting for Post-Traumatic Stress Disorder

N/A
Recruiting
Led By Ruth A Lanius, MD, PhD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18 and 65
Be older than 18 years old
Must not have
Current participation in counseling more extensive than supportive therapy (e.g., exposure therapy, Cognitive-Behavioral Therapy would be an exclusion)
History of neurological disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Summary

This trial will test whether Deep Brain Reorienting (DBR) is an effective treatment for PTSD. Participants will be assigned to either the DBR treatment or a wait-list condition.

Who is the study for?
This trial is for English-speaking adults aged 18-65 with PTSD who might gain from short-term trauma therapy. It's not for those with implants or conditions unsafe for high-strength fMRI, significant head injuries, untreated major illnesses, neurological disorders, extensive current counseling (like exposure therapy), severe mental distress unsuitable for brief treatment, developmental disorders, bipolar or psychotic history, or recent substance abuse.Check my eligibility
What is being tested?
The study tests Deep Brain Reorienting (DBR) as a treatment for PTSD. Participants will be randomly assigned to either receive DBR therapy or placed on a wait-list as part of the control group to compare outcomes between the two sets.See study design
What are the potential side effects?
While specific side effects are not listed here due to the nature of psychological interventions like DBR being less likely to have physical side effects compared to medication-based treatments; participants may experience emotional discomfort during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not currently in any intensive counseling like CBT or exposure therapy.
Select...
I have a history of a neurological disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in PTSD symptoms from baseline as measured by the Clinician Administered PTSD Scale (CAPS) at post-treatment assessment
change in PTSD symptoms from post-treatment assessment as measured by the Clinician Administered PTSD Scale (CAPS) at follow-up assessment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: DBR ConditionExperimental Treatment1 Intervention
Involves 8 weekly sessions of DBR treatment.
Group II: Wait-list ConditionActive Control1 Intervention
No intervention for approximately 8 weeks.

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
666 Previous Clinical Trials
414,142 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,354 Previous Clinical Trials
26,460,395 Total Patients Enrolled
Ruth A Lanius, MD, PhDPrincipal InvestigatorLawson Health Research Institute
1 Previous Clinical Trials
~3 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top